Health News & Press Release Distribution

Health

APAC
Global

Medical Tourism Moonshot: Breaking the Barriers to Quality Healthcare

PALM BEACH GARDENS, Fla., March 15, 2023 /PRNewswire/ -- The Medical Tourism Association in collaboration with Global Healthcare Resources and the International Healthcare Research Center have launched the firstMedical Tourism Moonshot to break down the major barriers preventing access and growth...

2023-03-15 02:55 2539

Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011

SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single cente...

2023-03-14 23:42 2211

Picarro's New 1-ppb Class Chemical Metrology Solution for Lithography Process Tool Monitoring Enables Semiconductor Fabs to Improve Process Control

SLiM 100 delivers real-time detection and quantification of VOCs to the 1 ppb level SANTA CLARA, Calif., March 14, 2023 /PRNewswire/ -- Picarro Inc., a leading provider of chemical metrology systems for advanced semiconductor fabs, today announced theSLiM 100 Lithography Process Tool Monitoring ...

2023-03-14 22:10 2884

Picarro's New 1-ppb Class Chemical Metrology Solution for Lithography Process Tool Monitoring Enables Semiconductor Fabs to Improve Process Control

USAID-FUNDED PROJECT RECOGNIZES EIGHT ORGANIZATIONS FOR LEADERSHIP IN ADOPTING ANTIMICROBIAL USE STEWARDSHIP PRINCIPLES

Developed by the International Poultry Council, the principles aim to optimize animal health to reduce reliance on antimicrobials TUCKER, Ga., March 14, 2023 /PRNewswire/ -- The International Poultry Council (IPC) is pleased to announce eight private-sector organizations have recognized the impo...

2023-03-14 21:00 2455

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

New Business Strategy Focused on Precision Oncology LONDON and HONG KONG, March 14, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full yea...

2023-03-14 20:56 7949

Servier's Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)

* Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years * Endpoints met in a prespecified interim analysis * vorasidenib granted fast track designation by U.S. Food & Drug Administration (FDA) PARI...

2023-03-14 20:24 2353

Servier's Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)

Ajinomoto Bio-Pharma Services Awarded Three 'CDMO Leadership Awards'

SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility,...

2023-03-14 20:05 1767

Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma

NANJING, China, March 14, 2023 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) (Simcere), an innovative global biopharmaceutical company, announced today that Simcere Zaiming, an innovative oncology pharmaceutical company of Simcere has entered into a clinical collaboration agreeme...

2023-03-14 20:00 2487

magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022

SUZHOU, China, March 14, 2023 /PRNewswire/ -- magAssist Inc. ("magAssist"), an innovator of medical devices has been named in authoritative international medical technology magazine MedTech Outlook's list

2023-03-14 18:30 1722

So-Young to Report Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

BEIJING, March 14, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its fina...

2023-03-14 17:30 2040

Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer

HONG KONG, March 14, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-specific antibody, AK104), the world's first approved and marketed dual-immune checkpoint bi-specific antib...

2023-03-14 17:01 1393

OSANO Debuts Latest Products at COSMOPROF 2023

BOLOGNA, Italy, March 14, 2023 /PRNewswire/ -- COSMOPROF WORLDWIDE BOLOGNA, one of the most influential global events dedicated to all facets of the beauty industry,is taking place from the 17th to 20th, March, 2023. OSANO launched a series of top-notch products, including Beauty Equipment, Body ...

2023-03-14 16:48 1489

DeepCare debuts at IDS Cologne 2023

COLOGNE, Germany, March 14, 2023 /PRNewswire/ -- DeepCare, a leading AI solution provider for dental care, debuts its latest innovative products at the International Dental Show (IDS) inCologne, Germany, from March 14th to 18th, 2023. IDS is the world's largest and most influential dental exhibit...

2023-03-14 16:00 1675

Antengene Announces IND Approval for the Phase I CLINCH Trial of ATG-022 (Claudin 18.2 ADC) for the Treatment of Advanced or Metastatic Solid Tumors in China

- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antigen (TAA) Claudin 18.2. - The Phase I CLINCH trial is designed to evaluate the safety, pharmacology, and preliminary efficacy of ATG-022 monotherapy in pat...

2023-03-14 12:29 2560

BEYOND Expo Back in Macao for 2023 to See "Technology Redefined" in one of Asia's Biggest Tech Events

MACAO, March 14, 2023 /PRNewswire/ -- Now on its third edition, BEYOND International Technology Innovation Expo (BEYOND Expo) returns to its real-world conference format inMacao from May 10 to 12, 2023. The live-streamed and in-person conference format will provide exhibitors and attendees with m...

2023-03-14 09:00 3051

BEYOND Expo Back in Macao for 2023 to See

Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management

SINGAPORE, March 14, 2023 /PRNewswire/ -- Qritive, a leading developer of artificial intelligence (AI)-powered cancer diagnostics, and, Corista, a leading provider of clinical, research and educational digital pathology image management solutions, are announcing a new partnership in digital patho...

2023-03-14 08:01 2693

Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

SHANGHAI, March 14, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") reported positive topline results from the global, randomized, double-blind, p...

2023-03-14 07:30 2467

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment

TAIPEI, March 14, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S.,Canada, European Union, Great Britain, and Israel for spinal ...

2023-03-14 06:00 2134

Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU

MELBOURNE, Australia, March 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

2023-03-14 05:11 1854

Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar

International partnership will see sensor installations in senior care facilities in all of Austco's operating regions, includingAustralia, the UK, Canada, and the US. DALLAS and TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Austco , an international manufacturer of n...

2023-03-13 23:08 2363